本文選題：可回收腔靜脈濾器　切入點：靜脈血栓栓塞性疾病　出處：《浙江大學(xué)》2012年碩士論文　論文類型：學(xué)位論文

【摘要】：背景 可回收腔靜脈濾器(Retrievable Vena Cava Filter, RVCF)是一種新型濾器,目前國內(nèi)未見對RVCF使用指證、回收率及其可能影響因素的系統(tǒng)性臨床研究,我們回顧性分析2009年6月至2011年6月在我院接受RVCF植入術(shù)的患者資料,嘗試對RVCF的應(yīng)用指證、回收率及其影響因素等方面進行初步探討。 方法 對2009年6月至2011年6月在我院接受RVCF植入的102例患者資料進行回顧性分析,觀察植入濾器的臨床指證,根據(jù)是否回收濾器分為濾器回收組和濾器留置組,比較兩組患者的一般資料(年齡、性別、BMI、有無高凝傾向、下肢深靜脈血栓、惡性腫瘤)和植入指證,并進行統(tǒng)計分析。 結(jié)果 共有96例患者進入本次研究,其中70例成功回收濾器,嘗試回收率為72.9%,回收成功率為100%。植入指證前三位分別為：抗凝禁忌(31.3%)、取/溶栓治療(28.1%)、抗凝并發(fā)癥(9.4%)。高齡(比值比0.149,95%可信區(qū)間0.034-0.651,P=0.005)、惡性腫瘤(比值比0.298,95%可信區(qū)間0.108-0.827,P=0.017)、植入指證為DVT伴抗凝失敗(比值比0.061,95%可信區(qū)間0.007-0.550,P=0.001)和DVT抗凝并發(fā)癥(比值比0.255,95%可信區(qū)間0.063-1.036,P=0.043)是影響RVCF回收的因素。 結(jié)論 RVCF是預(yù)防肺動脈栓塞的安全有效手段。經(jīng)過規(guī)范回收前評估后,RVCF具有較高的回收率。高齡、惡性腫瘤及植入指證是影響RVCF回收率的主要因素,在這些患者中使用RVCF并不比永久型腔靜脈濾器更有回收優(yōu)勢。
[Abstract]:background
Recyclable vena cava filter (Retrievable Vena Cava Filter, RVCF) is a new type of filter, at present there is no use of RVCF to testify, the recovery rate and may affect the system of factors: a clinical study, we retrospectively analyzed from June 2009 to June 2011 treated with RVCF implantation in our hospital, try to use against RVCF the recovery and its influencing factors were discussed.
Method
The data of 102 patients from June 2009 to June 2011 underwent RVCF implantation in our hospital were retrospectively analyzed. The clinical observation that implantation of the filter, according to whether the recovery filter into the filter recovery group and filter indwelling group, compared two groups of patients with general information (age, gender, BMI, there is no hypercoagulability, deep vein thrombosis, malignant tumor) and implantation of evidence, and statistical analysis.
Result
A total of 96 patients entered the study, including 70 cases of successful recovery filter, try the rate of recovery was 72.9%, the success rate of recovery is 100%. implantation against the top three were: (31.3%), take the contraindications to anticoagulation / thrombolytic therapy (28.1%), anticoagulation complications (9.4%). Age (odds ratio 0.149,95% confidence interval 0.034-0.651, P=0.005), malignancy (odds ratio 0.298,95% CI 0.108-0.827, P=0.017), charged with DVT implantation anticoagulation failure (odds ratio 0.061,95% CI 0.007-0.550, P=0.001) and DVT anticoagulation complications (odds ratio 0.255,95% CI 0.063-1.036, P=0.043) is the influence factors of RVCF recovery.
conclusion
RVCF is a safe and effective method in the prevention of pulmonary embolism. After evaluating standard recycling before and after recovery. RVCF has a higher rate of elderly, malignant tumor and implantation that is the main factor affecting the recovery rate of RVCF, the use of RVCF in these patients is not better than permanent cava filter recovery more advantages.

【學(xué)位授予單位】：浙江大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2012
【分類號】：R563.5

【共引文獻(xiàn)】

相關(guān)期刊論文 前1條

1 栗力,朱占來,董雙忠,崔若昱;經(jīng)皮小切口下腔靜脈濾器置入術(shù)的臨床應(yīng)用──附預(yù)防急性肺栓塞三例分析[J];天津醫(yī)藥;1999年03期

相關(guān)碩士學(xué)位論文 前3條

1 程杰;陶瓷涂層腔靜脈濾器預(yù)防置入術(shù)后繼發(fā)性血栓形成的實驗研究[D];復(fù)旦大學(xué);2008年

2 姜明明;下腔靜脈濾器預(yù)防肺栓塞的系統(tǒng)評價與Meta-分析[D];河北醫(yī)科大學(xué);2009年

3 任俊怡;下腔靜脈濾器置入術(shù)后傾斜和穿孔的CT隨訪結(jié)果[D];南京醫(yī)科大學(xué);2013年

，

本文編號：1569260